using mrd to inform allocation of stem cell transplants in all and aml
Published 6 years ago • 110 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
2:23
the role of mrd monitoring using mfc for aml: a real-world study
-
2:00
haploidentical transplantation for aml with mrd at transplantation
-
4:15
using mrd to guide post-allosct treatment decisions in aml
-
3:48
mrd-driven hsct for all
-
1:23
indications for autologous stem cell transplantation in aml
-
1:50
the possibility of using mrd status to drive treatment in aml
-
1:05
the importance of using mrd to guide treatment decisions in all
-
8:53
how is mrd testing done?
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll
-
7:46
updates in aml treatment and research from asco 2023
-
1:37
the importance of mrd assessment before allosct in all
-
0:48
pre-measure study: assessing the role of ngs mrd in patients with aml receiving sct
-
1:32
methods to evaluate mrd in aml
-
2:55
using mrd to guide treatment decisions during sct in multiple myeloma
-
4:11
expanding access to stem cell transplantation & car-t therapy in latin america
-
1:04
using mrd to identify which patients with aml will benefit the most from transplantation
-
4:21
mrd as a monitoring technique of allosct and car-t in aml/all
-
1:39
an insight into mrd monitoring and mrd-driven treatment in aml
-
1:45
mrd detection techniques in aml: pros and cons
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
1:26
the current role of mrd in aml and challenges with implementing this in clinical practice
-
6:39
molecular techniques for monitoring mrd in aml